GGrantIndex
Sort

261,768 grants matching gene therapy

Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research

$931,042
Xihong Lin · Harvard School Of Public Health · R35 · FY2021 · CA

Genomic instability in aging and cancer

$931,038
Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL

Virological Measurements of Cryptic Replication

$930,924
Mario Stevenson · University Of Minnesota · P01 · FY2010 · AI

Bacterial and host determinants of progression, manifestations and consequences of TB

$930,827
Reynaldo Dietze · Rutgers Biomedical And Health Sciences · U19 · FY2023 · AI

Retrovirus Assembly and Maturation

$930,640
Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Molecular heterogeneity of liver cancer and its clinical impacts

$930,599
Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

University of Pennsylvania Patient-derived Xenograft Development and Trials Center

$930,590
Martin Carroll · University Of Pennsylvania · U54 · FY2023 · CA

COP Laboratory

$930,529
Amy Leblanc · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission

$930,504
Jonah B. Sacha · Oregon Health & Science University · R01 · FY2021 · AI

Systems Biology of Angiogenesis in Peripheral Arterial Disease

$930,501
Aleksander S. Popel · Johns Hopkins University · R01 · FY2012 · HL

Defining and Manipulating Epigenomic Regulators in Endogenous Systems

$930,474
Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Evaluating Whether a Concurrent Retinoid X Receptor Agonist can Enhance the Efficacy of the HER2-IGFPB2-IGF1R Vaccine in Eliminating Existing Ductal Carcinoma in Situ and Preventing Progression of Inv

$930,464
Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2018 · CA

Undetected Drug resistance and Tolerance in lesions of recurrent TB

$930,462
Faramarz Valafar · San Diego State University · R01 · FY2025 · AI

Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells

$930,446
David D Ho · Aaron Diamond Aids Research Center · R01 · FY2017 · AI

Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy

$930,383
Joshua Aiden Hill · Fred Hutchinson Cancer Center · R01 · FY2023 · CA

Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies

$930,277
Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Ataxin-2 complex proteins in neurodegeneration.

$930,250
Stefan M. Pulst · Utah State Higher Education System--University Of Utah · R35 · FY2025 · NS

Ataxin-2 complex proteins in neurodegeneration.

$930,250
Stefan M. Pulst · University Of Utah · R35 · FY2023 · NS

Ataxin-2 complex proteins in neurodegeneration.

$930,250
Stefan M. Pulst · University Of Utah · R35 · FY2022 · NS

Role of Tumor Stroma in Therapeutic Response and Resistance

$930,118
Lynda Chin · University Of Tx Md Anderson Can Ctr · U54 · FY2011 · CA

Inborn Errors of Cholesterol Synthesis

$930,036
Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD

Preclinical Mouse Models of Thyroid Cancer

$930,012
Sheue-Yann Cheng · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

AIBP therapy

$930,000
Yury Miller · University Of California, San Diego · R35 · FY2021 · HL

AIBP therapy

$930,000
Yury Miller · University Of California, San Diego · R35 · FY2023 · HL

AIBP therapy

$930,000
Yury Miller · University Of California, San Diego · R35 · FY2017 · HL